Craig Hallum Lowers Aspen Aerogels (NYSE:ASPN) Price Target to $18.00

Aspen Aerogels (NYSE:ASPN) had its target price reduced by equities researchers at Craig Hallum from $21.00 to $18.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the construction company’s stock. Craig Hallum’s price objective indicates a potential upside of 107.71% from the stock’s current price.

Several other research firms have also recently weighed in on ASPN. Piper Sandler decreased their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Seaport Res Ptn cut Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Saturday, February 8th. Finally, Roth Mkm decreased their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $24.67.

Aspen Aerogels Trading Down 3.7 %

Aspen Aerogels stock opened at $8.67 on Friday. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The business’s fifty day simple moving average is $12.17 and its two-hundred day simple moving average is $18.46. Aspen Aerogels has a 12 month low of $8.25 and a 12 month high of $33.15. The company has a market capitalization of $711.05 million, a price-to-earnings ratio of 867.47 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. As a group, equities analysts predict that Aspen Aerogels will post 0.12 earnings per share for the current fiscal year.

Institutional Trading of Aspen Aerogels

Hedge funds have recently bought and sold shares of the stock. Lord Abbett & CO. LLC bought a new stake in Aspen Aerogels during the third quarter valued at about $10,126,000. Oppenheimer & Co. Inc. grew its holdings in Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock valued at $2,839,000 after purchasing an additional 64,154 shares during the period. Sanders Morris Harris LLC grew its holdings in Aspen Aerogels by 337.5% during the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after purchasing an additional 27,000 shares during the period. Penserra Capital Management LLC bought a new stake in Aspen Aerogels during the third quarter valued at about $1,342,000. Finally, Geode Capital Management LLC grew its holdings in Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock valued at $38,385,000 after purchasing an additional 75,024 shares during the period. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.